Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA: A Cancer J Clin. 2022;72(1):7–33. https://doi.org/10.3322/caac.21708.

Article  Google Scholar 

Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A J Clin. 2021;71(3):209–49. https://doi.org/10.3322/caac.21660.

Article  Google Scholar 

Schuurman MS, Kruitwagen R, Portielje JEA, Roes EM, Lemmens V, van der Aa MA. Treatment and outcome of elderly patients with advanced stage ovarian cancer: A nationwide analysis. Gynecol Oncol. 2018;149(2):270–4. https://doi.org/10.1016/j.ygyno.2018.02.017.

Article  PubMed  Google Scholar 

Filippova OT, Tin AL, Alonso J, Vickers AJ, Tew WP, Gardner GJ, Sonoda Y, Roche KL, Zivanovic O, Chi DS, et al. Frailty based on the memorial Sloan Kettering Frailty Index is associated with surgical decision making, clinical trial participation, and overall survival among older women with ovarian cancer. Gynecol Oncol. 2021;161(3):687–92. https://doi.org/10.1016/j.ygyno.2021.03.016.

Article  PubMed  PubMed Central  Google Scholar 

Fagotti A, Ferrandina G, Fanfani F, Ercoli A, Lorusso D, Rossi M, Scambia G. A laparoscopy-based score to predict surgical outcome in patients with advanced ovarian carcinoma: a pilot study. Ann Surg Oncol. 2006;13(8):1156–61. https://doi.org/10.1245/aso.2006.08.021.

Article  PubMed  Google Scholar 

Suidan RS, Ramirez PT, Sarasohn DM, Teitcher JB, Mironov S, Iyer RB, Zhou Q, Iasonos A, Paul H, Hosaka M, et al. A multicenter prospective trial evaluating the ability of preoperative computed tomography scan and serum CA-125 to predict suboptimal cytoreduction at primary debulking surgery for advanced ovarian, fallopian tube, and peritoneal cancer. Gynecol Oncol. 2014;134(3):455–61. https://doi.org/10.1016/j.ygyno.2014.07.002.

Article  PubMed  PubMed Central  Google Scholar 

Suidan RS, Leitao MM Jr, Zivanovic O, Gardner GJ, Long Roche KC, Sonoda Y, Levine DA, Jewell EL, Brown CL, Abu-Rustum NR, et al. Predictive value of the Age-Adjusted Charlson Comorbidity Index on perioperative complications and survival in patients undergoing primary debulking surgery for advanced epithelial ovarian cancer. Gynecol Oncol. 2015;138(2):246–51. https://doi.org/10.1016/j.ygyno.2015.05.034.

Article  PubMed  PubMed Central  Google Scholar 

Mallen A, Todd S, Robertson SE, Kim J, Sehovic M, Wenham RM, Extermann M, Chon HS. Impact of age, comorbidity, and treatment characteristics on survival in older women with advanced high grade epithelial ovarian cancer. Gynecol Oncol. 2021;161(3):693–9. https://doi.org/10.1016/j.ygyno.2021.03.008.

Article  PubMed  Google Scholar 

Kaplan MH, Feinstein AR. The importance of classifying initial co-morbidity in evaluating the outcome of diabetes mellitus. J Chronic Dis. 1974;27(7–8):387–404. https://doi.org/10.1016/0021-9681(74)90017-4.

Article  PubMed  Google Scholar 

Klabunde CN, Potosky AL, Legler JM, Warren JL. Development of a comorbidity index using physician claims data. J Clin Epidemiol. 2000;53(12):1258–67. https://doi.org/10.1016/s0895-4356(00)00256-0.

Article  PubMed  Google Scholar 

Piccirillo JF. Importance of comorbidity in head and neck cancer. Laryngoscope. 2000;110(4):593–602. https://doi.org/10.1097/00005537-200004000-00011.

Article  PubMed  Google Scholar 

Binder PS, Peipert JF, Kallogjeri D, Brooks RA, Massad LS, Mutch DG, Powell MA, Thaker PH, McCourt CK. Adult comorbidity evaluation 27 score as a predictor of survival in endometrial cancer patients. Am J Obstet Gynecol. 2016;215(6):766.e761-766.e769. https://doi.org/10.1016/j.ajog.2016.07.035.

Article  Google Scholar 

Schimansky S, Lang S, Beynon R, Penfold C, Davies A, Waylen A, Thomas S, Pring M, Pawlita M, Waterboer T, et al. Association between comorbidity and survival in head and neck cancer: results from Head and Neck 5000. Head Neck. 2019;41(4):1053–62. https://doi.org/10.1002/hed.25543.

Article  PubMed  Google Scholar 

Paleri V, Wight RG. Applicability of the adult comorbidity evaluation - 27 and the Charlson indexes to assess comorbidity by notes extraction in a cohort of United Kingdom patients with head and neck cancer: a retrospective study. J Laryngol Otol. 2002;116(3):200–5. https://doi.org/10.1258/0022215021910528.

Article  PubMed  Google Scholar 

Østhus AA, Aarstad AK, Olofsson J, Aarstad HJ. Prediction of survival by pretreatment health-related quality-of-life scores in a prospective cohort of patients with head and neck squamous cell carcinoma. JAMA Otolaryngol Head Neck Surg. 2013;139(1):14–20. https://doi.org/10.1001/jamaoto.2013.1056.

Article  PubMed  Google Scholar 

Aletti GD, Dowdy SC, Podratz KC, Cliby WA. Relationship among surgical complexity, short-term morbidity, and overall survival in primary surgery for advanced ovarian cancer. Am J Obstet Gynecol. 2007;197(6):676.e671-677. https://doi.org/10.1016/j.ajog.2007.10.495.

Article  Google Scholar 

Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240(2):205–13. https://doi.org/10.1097/01.sla.0000133083.54934.ae.

Article  PubMed  PubMed Central  Google Scholar 

Janssen-Heijnen ML, Houterman S, Lemmens VE, Louwman MW, Maas HA, Coebergh JW. Prognostic impact of increasing age and co-morbidity in cancer patients: a population-based approach. Crit Rev Oncol Hematol. 2005;55(3):231–40. https://doi.org/10.1016/j.critrevonc.2005.04.008.

Article  PubMed  Google Scholar 

Tseng CH. Diabetes and breast cancer in Taiwanese women: a detection bias? Eur J Clin Invest. 2014;44(10):910–7. https://doi.org/10.1111/eci.12323.

Article  PubMed  Google Scholar 

Kumar A, Langstraat CL, DeJong SR, McGree ME, Bakkum-Gamez JN, Weaver AL, LeBrasseur NK, Cliby WA. Functional not chronologic age: frailty index predicts outcomes in advanced ovarian cancer. Gynecol Oncol. 2017;147(1):104–9. https://doi.org/10.1016/j.ygyno.2017.07.126.

Article  PubMed  Google Scholar 

Handley KF, Sood AK, Molin GZD, Westin SN, Meyer LA, Fellman B, Soliman PT, Coleman RL, Fleming ND. Frailty repels the knife: The impact of frailty index on surgical intervention and outcomes. Gynecol Oncol. 2022;166(1):50–6. https://doi.org/10.1016/j.ygyno.2022.05.009.

Article  PubMed  Google Scholar 

Slavchev S, Kornovski Y, Yordanov A, Ivanova Y, Kostov S, Slavcheva S. Survival in advanced epithelial ovarian cancer associated with cardiovascular comorbidities and type 2 diabetes mellitus. Curr Oncol (Toronto, Ont). 2021;28(5):3668–82. https://doi.org/10.3390/curroncol28050313.

Article  Google Scholar 

Stone RL, Nick AM, McNeish IA, Balkwill F, Han HD, Bottsford-Miller J, Rupairmoole R, Armaiz-Pena GN, Pecot CV, Coward J, et al. Paraneoplastic thrombocytosis in ovarian cancer. N Engl J Med. 2012;366(7):610–8. https://doi.org/10.1056/NEJMoa1110352.

Article  PubMed  PubMed Central  Google Scholar 

Díaz-Montes TP, Zahurak ML, Giuntoli RL 2nd, Gardner GJ, Gordon TA, Armstrong DK, Bristow RE. Surgical care of elderly women with ovarian cancer: a population-based perspective. Gynecol Oncol. 2005;99(2):352–7. https://doi.org/10.1016/j.ygyno.2005.06.005.

Article  PubMed  Google Scholar 

John C, Bui A, Buckingham L, O’Donnell J, LeCroy K, Dockery L. Chemotherapy without cytoreduction of advanced stage epithelial ovarian cancer in the elderly population is associated with poor survival outcomes. Gynecol Oncol. 2022;166:S217–8.

Article  Google Scholar 

Fanfani F, Fagotti A, Salerno MG, Margariti PA, Gagliardi ML, Gallotta V, Vizzielli G, Panico G, Monterossi G, Scambia G. Elderly and very elderly advanced ovarian cancer patients: does the age influence the surgical management? European J Surg Oncol. 2012;38(12):1204–10. https://doi.org/10.1016/j.ejso.2012.08.003.

Article  Google Scholar 

Pinelli C, Morotti M, Casarin J, Tozzi R, Ghezzi F, Mavroeidis VK, Alazzam M, Soleymani Majd H. Interval debulking surgery for advanced ovarian cancer in elderly patients (≥70 y): does the age matter? J Investigative Surg. 2021;34(9):1023–30. https://doi.org/10.1080/08941939.2020.1733146.

Article  Google Scholar 

Kumar A, Janco JM, Mariani A, Bakkum-Gamez JN, Langstraat CL, Weaver AL, McGree ME, Cliby WA. Risk-prediction model of severe postoperative complications after primary debulking surgery for advanced ovarian cancer. Gynecol Oncol. 2016;140(1):15–21. https://doi.org/10.1016/j.ygyno.2015.10.025.

Article  PubMed  Google Scholar 

Straubhar AM, Wolf JL, Zhou MQC, Iasonos A, Cham S, Wright JD, Long Roche K, Chi DS, Zivanovic O. Advanced ovarian cancer and cytoreductive surgery: independent validation of a risk-calculator for perioperative adverse events. Gynecol Oncol. 2021;160(2):438–44. https://doi.org/10.1016/j.ygyno.2020.11.021.

Article  PubMed  Google Scholar 

Cham S, Chen L, St Clair CM, Hou JY, Tergas AI, Melamed A, Ananth CV, Neugut AI, Hershman DL, Wright JD. Development and validation of a risk-calculator for adverse perioperative outcomes for women with ovarian cancer. Am J Obstet Gynecol. 2019;220(6):571.e571-571.e578. https://doi.org/10.1016/j.ajog.2019.02.019.

Article  Google Scholar